EuBiologics gets WHO certification for cholera vaccine facility
Yena Kim
May 17, 2024 (Gmt+09:00)
South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vaccines Euvichol and Euvichol Plus has received prequalification (WHO-PQ) certification from the World Health Organization (WHO).
WHO-PQ is a system that evaluates the manufacturing process, quality, and clinical results of vaccines to certify their safety and efficacy.
WHO-PQ certification is mandatory to participate in global bids arranged by UN agencies such as UNICEF and the Pan American Health Organization.
With this certification, EuBiologics reported that it could increase its production of cholera vaccine bulk by over 60% compared to last year.
Until now, the manufacturing of cholera vaccine bulk was only available at Chuncheon Plant No. 1.